These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 2413432

  • 1. Changes in immunohistochemical staining in prostatic adenocarcinoma following diethylstilbestrol therapy.
    Grignon D, Troster M.
    Prostate; 1985; 7(2):195-202. PubMed ID: 2413432
    [Abstract] [Full Text] [Related]

  • 2. Immunohistochemical demonstration of tumor-associated antigens in prostatic carcinomas of various histological differentiations.
    Friedmann W, Steffens J, Lobeck H, Blümcke S, Nagel R.
    Eur Urol; 1985; 11(1):52-6. PubMed ID: 2580711
    [Abstract] [Full Text] [Related]

  • 3. The use of immunohistochemistry in metastatic prostatic adenocarcinoma to the breast.
    Green LK, Klima M.
    Hum Pathol; 1991 Mar; 22(3):242-6. PubMed ID: 1706305
    [Abstract] [Full Text] [Related]

  • 4. The relation of prostatic acid phosphatase and prostate specific antigen with tumour grade in prostatic adenocarcinoma: an immunohistochemical study.
    Ersev A, Ersev D, Turkeri L, Ilker Y, Simsek F, Kullu S, Akdas A.
    Prog Clin Biol Res; 1990 Mar; 357():129-34. PubMed ID: 1699237
    [Abstract] [Full Text] [Related]

  • 5. Changes in immunohistochemical staining of PSA, PAP, and TURP-27 following irradiation therapy for clinically localized prostate cancer.
    Grob BM, Schellhammer PF, Brassil DN, Wright GL.
    Urology; 1994 Oct; 44(4):525-9. PubMed ID: 7524238
    [Abstract] [Full Text] [Related]

  • 6. Prostate-specific antigen as a marker of adenocarcinoma of prostate.
    Kellokumpu-Lehtinen P, Nurmi M, Koskinen P, Irjala K.
    Urol Res; 1989 Oct; 17(4):245-9. PubMed ID: 2475959
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Multiple immunoperoxidase markers in benign hyperplasia and adenocarcinoma of the prostate.
    Ellis DW, Leffers S, Davies JS, Ng AB.
    Am J Clin Pathol; 1984 Mar; 81(3):279-84. PubMed ID: 6199966
    [Abstract] [Full Text] [Related]

  • 9. Immunohistochemical demonstration of cytokeratins in the human prostate.
    Wernert N, Seitz G, Goebbels R, Dhom G.
    Pathol Res Pract; 1986 Dec; 181(6):668-74. PubMed ID: 2436199
    [Abstract] [Full Text] [Related]

  • 10. Pre-treatment and post-treatment evaluation of prostatic adenocarcinoma for prostatic specific acid phosphatase and prostatic specific antigen by immunohistochemistry.
    Vernon SE, Williams WD.
    J Urol; 1983 Jul; 130(1):95-8. PubMed ID: 6191050
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prostate-specific antigen in the follow-up of prostatic adenocarcinoma treated with external beam radiation.
    Kellokumpu-Lehtinen P, Nurmi M, Koskinen P, Irjala K.
    Urol Int; 1991 Jul; 46(1):6-8. PubMed ID: 1708923
    [Abstract] [Full Text] [Related]

  • 13. The role of prostate specific antigen in the baseline assessment of patients undergoing hormone therapy for advanced prostate cancer.
    Emtage LA, Lewis PW, Blackledge GR.
    Br J Urol; 1987 Dec; 60(6):572-7. PubMed ID: 2447997
    [Abstract] [Full Text] [Related]

  • 14. Preliminary evaluation of measurement of serum prostate-specific antigen level in detection of prostate cancer.
    Wang TY, Kawaguchi TP.
    Ann Clin Lab Sci; 1986 Dec; 16(6):461-6. PubMed ID: 3800301
    [Abstract] [Full Text] [Related]

  • 15. Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma.
    Aprikian AG, Cordon-Cardo C, Fair WR, Reuter VE.
    Cancer; 1993 Jun 15; 71(12):3952-65. PubMed ID: 7685237
    [Abstract] [Full Text] [Related]

  • 16. Absence of serum prostate-specific antigen and loss of tissue immunoreactive prostatic markers in advanced prostatic adenocarcinoma after hormonal therapy: a report of two cases.
    Mai KT, Commons AS, Perkins DG, Yazdi HM, Collins JP.
    Hum Pathol; 1996 Dec 15; 27(12):1377-81. PubMed ID: 8958315
    [Abstract] [Full Text] [Related]

  • 17. Adenocarcinoma of the canine prostate: immunohistochemical examination for secretory antigens.
    McEntee M, Isaacs W, Smith C.
    Prostate; 1987 Dec 15; 11(2):163-70. PubMed ID: 2444955
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Role of prostate-specific antigen in prostatic carcinoma. Validity of an integrated methodologic approach and morpho-biological correlations].
    Tomasino RM, Lo Bianco A, Cacciatore M, Pavone C, Carreca I, Morello V, Salvato M, Florena AM, Pavone-Macaluso M.
    Pathologica; 1989 Dec 15; 81(1072):109-26. PubMed ID: 2475847
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.